Mitigating the Impact of Stigma and Shame Among MSM Living With HIV and Substance Use Disorders
Launched by MASSACHUSETTS GENERAL HOSPITAL · Jun 28, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a program called MATTER, which aims to help men who have sex with men (MSM) and gender minority individuals living with HIV and substance use disorders (SUDs). Many people in these groups face stigma and shame, which can make it harder for them to get the care they need to manage their HIV and improve their health. The MATTER program consists of five virtual sessions that focus on building self-care skills, increasing awareness of emotions, and promoting self-compassion. The goal is to reduce the negative effects of stigma and shame, making it easier for participants to engage in HIV care and achieve viral suppression, which means keeping the virus at low levels in their bodies.
To participate in this trial, individuals must be at least 18 years old, identify as MSM or a gender minority who has sex with men, and be living with HIV and a substance use disorder. They should also be experiencing feelings of stigma related to their HIV status or sexual orientation. Participants will need to communicate in English or Spanish and have access to a cell phone for text communication. The study is currently not recruiting, but it will take place in areas with varying levels of HIV resources, such as Boston and Miami. If you or someone you know fits these criteria, this trial could provide valuable support and resources for managing health and reducing stigma.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • HIV+
- • MSM or gender minority individuals who report having sex with men
- • Meet criteria for an illicit (not solely including tobacco, cannabis, or alcohol) SUD
- • Endorse internalized stigma related to HIV, substance use, sexual orientation, or gender-identity
- • Unsuppressed HIV VL (\>20 copies/mL).
- • Provide informed consent in English
- • Verbally communicate in English and read in English or Spanish
- • Be ≥18 years old
- • Provide evidence or documentation of HIV+ status
- • Release HIV-related health records
- • Have access to a cell phone with text capacity (study will supplement phones and plans as needed consistent with our pilot work).
- Exclusion Criteria:
- • Cisgender women
- • Cisgender heterosexual men
About Massachusetts General Hospital
Massachusetts General Hospital (MGH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing medical research and patient care. As a prominent teaching hospital affiliated with Harvard Medical School, MGH plays a pivotal role in clinical trials across a wide range of disciplines, including cardiology, oncology, neurology, and more. The institution is dedicated to fostering innovative research that translates into effective therapies and improved health outcomes. MGH's Clinical Trials Office provides comprehensive support to facilitate the design, implementation, and management of clinical studies, ensuring adherence to the highest ethical standards and regulatory compliance. With a focus on collaboration and patient-centered care, MGH strives to enhance medical knowledge and contribute to the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Miami, Florida, United States
Boston, Massachusetts, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported